Clinical Professor, Internal Medicine, University of Maryland School of Medicine
Infectious Disease
Dr. Harold C. Standiford, MD
|
|
Give Review
Dr. Harold C. Standiford is an expert in the field of Infectious Disease. He went to University of Maryland School of Medicine. University of Maryland School of Medicine is ranked 37/52 in Research/PrimaryCare. He has 1 awards "Whos Who in Medicine and Healthcare". Harold Standiford is a published doctor and has 99 publications published. The lastest was: 'Zidovudine treatment in patients with primary (acute) human immunodeficiency virus type 1 infection: a randomized, double-blind, placebo-controlled trial. DATRI 002 St...'
Publications
- Effectiveness of an antimicrobial polymer to decrease contamination of environmental surfaces in the clinical setting.
- Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program.
- Empiric antimicrobial therapy for Gram-negative sepsis: Back to the future.
- Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy.
- Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility.
- Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission.
- Methicillin-resistant Staphylococcus aureus infection and colonization among hospitalized prisoners.
- Value of performing active surveillance cultures on intensive care unit discharge for detection of methicillin-resistant Staphylococcus aureus.
- Video-based training increases sterile-technique compliance during central venous catheter insertion.
- Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.
- Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial.
- Methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci co-colonization.
- Preliminary assessment of an automated surveillance system for infection control.
- Aggressive control measures for resistant Acinetobacter baumannii and the impact on acquisition of methicillin-resistant Staphylococcus aureus and vancomycin-resistant...
- Worldwide assessment of linezolid's clinical safety and tolerability: comparator-controlled phase III studies.
- Spinal epidural abscess: a report of 40 cases and review.
- MRSA colonization and the risk of MRSA bacteraemia in hospitalized patients with chronic ulcers.
- Pharmacokinetics of ceftazidime, alone or in combination with piperacillin or tobramycin, in the sera of cancer patients.
- Comparative study of the serum bactericidal activity of cefoperazone alone and in combination with amikacin or mezlocillin against gram-negative bacilli and Staphyloco...
- Correlation of predicted serum bactericidal activities and values measured in volunteers.
- Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin.
- Tolerance and pharmacokinetic interactions of rifabutin and azithromycin.
- Serum bactericidal test in volunteers--a review.
- Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphate.
- Emergence of resistance to carbapenem antibiotics in Pseudomonas aeruginosa.
- Effect of renal function on the bioavailability of ciprofloxacin.
- Population pharmacokinetics of zidovudine. The Veterans Administration Cooperative Studies Group.
- Comparison of the pharmacokinetics of ceftazidime and moxalactam and their microbiological correlates in volunteers.
- Integration of selected pharmacologic and microbiologic properties of three new beta-lactam antibiotics: a hypothesis for rational comparison.
- Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.
- A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy.
- Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcilli...
- Antibiotic combinations against gram-negative bacilli and Staphylococcus aureus in cancer patients: comparative in-vitro and in-vivo activity of cefoperazone and mezlo...
- The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.
- Laboratory and clinical experience with cephalexin.
- Laboratory and clinical studies of carbenicillin against gram-negative bacilli.
- Clinical pharmacology of carbenicillin compared with other penicillins.
- Mechanisms responsible for plasma levels of nafcillin lower than those of oxacillin.
- Development of staphylococci cross-resistant to cephalexin and methicillin.
- Gentamicin: in vitro studies.
- Carbenicillin in treatment of severe infections due to pseudomonas.
- The carbenicillin-gentamicin combination against Pseudomonas aeruginosa. Correlation of effect with gentamicin sensitivity.
- Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.
- Measurement of amikacin in serum by a latex agglutination inhibition test.
- Comparative pharmacokinetics and serum bactericidal activity of mezlocillin, ticarcillin and piperacillin, with and without gentamicin.
- Latamoxef in combination with aminoglycosides against Pseudomonas aeruginosa: similarity with ticarcillin.
- Safety and tolerability of multiple doses of imipenem/cilastatin.
- Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer.
- Pharmacokinetic profile of imipenem/cilastatin in normal volunteers.
- Activity of novobiocin against methicillin-resistant Staphylococcus aureus.
- Absolute oral bioavailability of ciprofloxacin.
- Dose ranging study and constant infusion evaluation of ciprofloxacin.
- Steady-state serum pharmacokinetics of novobiocin and rifampin alone and in combination.
- Comparison of the latex agglutination inhibition assay for tobramycin with radioimmunoassay.
- Antibiotic synergism and response in gram-negative bacteremia in granulocytopenic cancer patients.
- Methicillin-resistant Staphylococcus aureus infections: it's time to get tough.
- Accuracy of patient recall for date of peripheral intravenous catheter insertion.
- Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin.
- Candidal suppurative peripheral thrombophlebitis: recognition, prevention, and management.
- Bactericidal activity of ciprofloxacin compared with that of cefotaxime in normal volunteers.
- Effect of dose size on bioavailability of ciprofloxacin.
- Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function.
- Double-blind, prospective, multicenter trial comparing ceftazidime with moxalactam in the treatment of serious gram-negative infections.
- Technical aspects and clinical correlations of the serum bactericidal test.
- Steady-state pharmacokinetics of imipenem in febrile neutropenic cancer patients.
- Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration...
- Relationships between renal function and disposition of oral ciprofloxacin.
- Prospective microbiologic surveillance in control of nosocomial methicillin-resistant Staphylococcus aureus.
- A multicenter, randomized, controlled trial of three preparations of low-dose oral alpha-interferon in HIV-infected patients with CD4+ counts between 50 and 350 cells/...
- Correlation of quantitative bone marrow and blood cultures in AIDS patients with disseminated Mycobacterium avium complex infection.
- Zidovudine treatment in patients with primary (acute) human immunodeficiency virus type 1 infection: a randomized, double-blind, placebo-controlled trial. DATRI 002 St...
- Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.
- Facet and facet-joint infections: case report and review.
- Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management.
- Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis.
- Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: p...
- Serum inhibitory and bactericidal activity against methicillin-resistant Staphylococcus aureus in volunteers receiving novobiocin and rifampin alone and in combination.
- Impact of dosing schedule upon suppression of a retrovirus in a murine model of AIDS encephalopathy.
- Prophylaxis against enterococcal endocarditis: comparison of the aminoglycoside component of parenteral antimicrobial regimens.
- Latex agglutination inhibition card test for gentamicin assay: clinical evaluation and comparison with radioimmunoassay and bioassay.
- A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections.
- Prospective evaluation of the risk of bacteremia and the role of antibiotics in ERCP.
- Multiple-dose pharmacokinetics of imipenem-cilastatin.
- The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers.
- Role of antimicrobial synergism in infected granulocytopenic patients.
- False elevation in serum creatinine levels.
- Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
- Postantibiotic effect of imipenem on Pseudomonas aeruginosa.
- Bactericidal activity of ceftazidime in serum compared with that of ticarcillin combined with amikacin.
- Anaerobic bacteriuria in a male urologic outpatient population.
- BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa.
- Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.
- Comparison of serum bactericidal activity among three antimicrobial combinations.
- Parenteral prophylaxis against enterococcal endocarditis.
- Gentamicin and ticarcillin serum levels.
- Pirbenicillin: comparison with carbenicillin and BL-P1654, alone and with gentamicin, against Pseudomonas aeruginosa.
- Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and ca...
- Amikacin and cephalothin: empiric regimen for granulocytopenic cancer patients.
Schools
University of Maryland At Baltimore Professional Schools
University MD Hospital
University Wash Hospital
University of Washington
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
University of Washington -
University of Maryland -
University of Maryland School of Medicine
Hospital
-
University of Maryland Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Frank M. Calia, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chandralekha Banerjee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert C. Bollinger Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer S. Huson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cecilia P. Johnston, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen Berry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Donnenberg, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Shmuel Shoham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan Zenilman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald P. Rabinowitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Larry W. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcos A. Wolff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dimitra Mitsani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kerri A. Thom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Izukanji T. Sikazwe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick J. Cahill, MD |
|
|
Dr. Krirk Asavametha, MD |